Page last updated: 2024-09-04

levofloxacin and AIDS-Related Opportunistic Infections

levofloxacin has been researched along with AIDS-Related Opportunistic Infections in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (21.43)18.2507
2000's5 (35.71)29.6817
2010's6 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bang, ND; Caws, M; Chau, NV; Chau, TT; Day, JN; Dung, NH; Farrar, JJ; Ha, DT; Heemskerk, AD; Hien, NQ; Hien, TT; Lan, NH; Lan, NN; Lan, NT; Loc, PP; Mai, NT; Merson, L; Phong, le T; Phu, NH; Thinh, TT; Thwaites, GE; Vien, NN; Wolbers, M; Yen, NT1
Donald, PR1
Bang, ND; Heemskerk, AD; Thwaites, GE1
Aarnoutse, R; Ruslami, R; van Crevel, R1
Boeree, MJ; Gillespie, SH; Hoelscher, M1
Nowakowski, J; Sudhindra, P1
Carosi, G; Casari, S; Chiodera, A; Moretti, F; Quiros-Roldan, E; Viale, P1
Brade, V; Enzensberger, R; Gruschke, A1
Alba, L; Antinori, A; Boumis, E; Festa, A; Marconi, P; Paglia, MG; Pucillo, LP; Visca, P1
García-Cruz, A; Mateu, L; Pedro-Botet, ML; Rey-Joly, C; Roure, S; Sabria, M; Sopena, N; Tural, C1
De Souza, MV; Junior, IN; Lourenço, MC1
Chirgwin, K; El Sadr, WM; Hafner, R; Heifets, LB; Klein, O; Kreiswirth, BN; Matts, JP; Musser, JM; Nelson, ET; Perlman, DC; Salomon, N; Telzak, EE1
Chirgwin, KD; Cohn, DL; el-Sadr, WM; Hafner, R; Heifets, L; Jones, BE; Klein, O; Matts, JP; Medard, F; Mildvan, D; Nelson, ET; Olibrice, M; Perlman, DC; Salomon, N; Telzak, EE1
Benson, CA; Chirgwin, KD; El-Sadr, WM; Matts, JP; Nelson, ET; Perlman, DC; Sepkowitz, KA; Telzak, EE1

Trials

3 trial(s) available for levofloxacin and AIDS-Related Opportunistic Infections

ArticleYear
Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis.
    The New England journal of medicine, 2016, Jan-14, Volume: 374, Issue:2

    Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Double-Blind Method; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; HIV Infections; Humans; Kaplan-Meier Estimate; Levofloxacin; Male; Middle Aged; Mycobacterium tuberculosis; Proportional Hazards Models; Rifampin; Tuberculosis, Meningeal

2016
Susceptibility to levofloxacin of Myocobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance. Community Programs for Clinical Research on AIDS 019 and the AIDS Clinica
    AIDS (London, England), 1997, Volume: 11, Issue:12

    Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin; Sputum; Tuberculosis

1997
Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Tr
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 26, Issue:5

    Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Levofloxacin; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Recurrence; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary

1998

Other Studies

11 other study(ies) available for levofloxacin and AIDS-Related Opportunistic Infections

ArticleYear
Chemotherapy for Tuberculous Meningitis.
    The New England journal of medicine, 2016, Jan-14, Volume: 374, Issue:2

    Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Female; Humans; Levofloxacin; Male; Rifampin; Tuberculosis, Meningeal

2016
Therapy for Tuberculous Meningitis.
    The New England journal of medicine, 2016, 06-02, Volume: 374, Issue:22

    Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Female; Humans; Levofloxacin; Male; Rifampin; Tuberculosis, Meningeal

2016
Therapy for Tuberculous Meningitis.
    The New England journal of medicine, 2016, 06-02, Volume: 374, Issue:22

    Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Female; Humans; Levofloxacin; Male; Rifampin; Tuberculosis, Meningeal

2016
Therapy for Tuberculous Meningitis.
    The New England journal of medicine, 2016, 06-02, Volume: 374, Issue:22

    Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Female; Humans; Levofloxacin; Male; Rifampin; Tuberculosis, Meningeal

2016
Therapy for Tuberculous Meningitis.
    The New England journal of medicine, 2016, 06-02, Volume: 374, Issue:22

    Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Female; Humans; Levofloxacin; Male; Rifampin; Tuberculosis, Meningeal

2016
Rhodococcus equi: pulmonary cavitation lesion in patient infected with HIV cured by levofloxacin and rifampicin.
    AIDS (London, England), 2002, Jul-05, Volume: 16, Issue:10

    Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; HIV Infections; Humans; Levofloxacin; Lung Diseases; Male; Ofloxacin; Rhodococcus equi; Rifampin

2002
[Osteomyelitis of the tibial head caused by Mycobacterium haemophilium in a patient with AIDS].
    Deutsche medizinische Wochenschrift (1946), 2002, Sep-20, Volume: 127, Issue:38

    Topics: Abscess; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Immunocompromised Host; Levofloxacin; Male; Middle Aged; Mycobacterium haemophilum; Mycobacterium Infections; Ofloxacin; Osteomyelitis; Recurrence; Rifabutin; Tibia

2002
Short Communication: Yersinia pseudotuberculosis septicemia in an HIV-infected patient failed HAART.
    AIDS research and human retroviruses, 2004, Volume: 20, Issue:7

    Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Ceftriaxone; Drug Therapy, Combination; Female; Humans; Levofloxacin; Ofloxacin; Sepsis; Treatment Failure; Yersinia pseudotuberculosis; Yersinia pseudotuberculosis Infections

2004
Severe Legionnaires' disease successfully treated with levofloxacin and azithromycin.
    Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:5

    Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Drug Therapy, Combination; Female; Humans; Legionnaires' Disease; Levofloxacin; Lung; Middle Aged; Ofloxacin; Radiography; Remission Induction

2006
In vitro activity of ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and gatifloxacin against multidrug-resistant Mycobacterium tuberculosis in Rio de Janeiro Brazil.
    Medecine et maladies infectieuses, 2007, Volume: 37, Issue:5

    Topics: AIDS-Related Opportunistic Infections; Brazil; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis

2007
Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Hea
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 1999, Volume: 3, Issue:4

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Chi-Square Distribution; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Levofloxacin; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pilot Projects; Prospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; United States

1999